Spineguard
SpineGuard SA provides designs, develops, and markets medical devices for spine in France and internationally. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, psifguard, and threaded PediGuard products; and DSG smart screw that allows for one step screw placement treatment. It also provides DSG (Dynamic Surgical Guidance) Connect app that allows collecti… Read more
Spineguard (ALSGD) - Total Assets
Latest total assets as of June 2025: €8.35 Million EUR
Based on the latest financial reports, Spineguard (ALSGD) holds total assets worth €8.35 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Spineguard - Total Assets Trend (2010–2024)
This chart illustrates how Spineguard’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Spineguard - Asset Composition Analysis
Current Asset Composition (December 2024)
Spineguard's total assets of €8.35 Million consist of 37.1% current assets and 62.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 8.7% |
| Accounts Receivable | €653.63K | 7.9% |
| Inventory | €861.83K | 10.5% |
| Property, Plant & Equipment | €387.37K | 4.7% |
| Intangible Assets | €1.42 Million | 17.3% |
| Goodwill | €3.08 Million | 37.5% |
Asset Composition Trend (2010–2024)
This chart illustrates how Spineguard's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Spineguard's current assets represent 37.1% of total assets in 2024, a decrease from 44.9% in 2010.
- Cash Position: Cash and equivalents constituted 8.7% of total assets in 2024, down from 31.1% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 54.0% of total assets, an increase from 53.0% in 2010.
- Asset Diversification: The largest asset category is goodwill at 37.5% of total assets.
Spineguard Competitors by Total Assets
Key competitors of Spineguard based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Spineguard - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Spineguard generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Spineguard is currently not profitable relative to its asset base.
Spineguard - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.07 | 1.34 | 0.54 |
| Quick Ratio | 0.82 | 1.01 | 0.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €206.57K | € 1.02 Million | € -2.88 Million |
Spineguard - Advanced Valuation Insights
This section examines the relationship between Spineguard's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.91 |
| Latest Market Cap to Assets Ratio | 0.69 |
| Asset Growth Rate (YoY) | -25.4% |
| Total Assets | €8.23 Million |
| Market Capitalization | $5.70 Million USD |
Valuation Analysis
Below Book Valuation: The market values Spineguard's assets below their book value (0.69 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Spineguard's assets decreased by 25.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Spineguard (2010–2024)
The table below shows the annual total assets of Spineguard from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €8.23 Million | -25.43% |
| 2023-12-31 | €11.04 Million | -4.07% |
| 2022-12-31 | €11.50 Million | -3.33% |
| 2021-12-31 | €11.90 Million | +47.65% |
| 2020-12-31 | €8.06 Million | -5.15% |
| 2019-12-31 | €8.50 Million | +8.14% |
| 2018-12-31 | €7.86 Million | -3.63% |
| 2017-12-31 | €8.15 Million | -13.36% |
| 2016-12-31 | €9.41 Million | -5.12% |
| 2015-12-31 | €9.92 Million | +15.87% |
| 2014-12-31 | €8.56 Million | -31.05% |
| 2013-12-31 | €12.41 Million | +53.39% |
| 2012-12-31 | €8.09 Million | -2.29% |
| 2011-12-31 | €8.28 Million | +11.64% |
| 2010-12-31 | €7.42 Million | -- |